达沙替尼治疗患者的结肠炎和慢性出血

Journal of cancer research & therapy Pub Date : 2017-06-02 DOI:10.14312/2052-4994.2017-6

L. Campiotti, M. Suter, B. Elena, S. Uccella, Grandi Am, L. Guasti

{"title":"达沙替尼治疗患者的结肠炎和慢性出血","authors":"L. Campiotti, M. Suter, B. Elena, S. Uccella, Grandi Am, L. Guasti","doi":"10.14312/2052-4994.2017-6","DOIUrl":null,"url":null,"abstract":"Dasatinib is a key therapeutic option in patients with chronic myeloid leukemia. Previous case reports associated it with acute colitis. This is another report that demonstrates a link between dasatinib and chronic colitis akin to inflammatory bowel disease, in patients undergoing therapy with dasatinib for a prolonged time.","PeriodicalId":90205,"journal":{"name":"Journal of cancer research & therapy","volume":"21 1","pages":"32-33"},"PeriodicalIF":0.0000,"publicationDate":"2017-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Colitis and chronic bleeding in patients treated with dasatinib\",\"authors\":\"L. Campiotti, M. Suter, B. Elena, S. Uccella, Grandi Am, L. Guasti\",\"doi\":\"10.14312/2052-4994.2017-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dasatinib is a key therapeutic option in patients with chronic myeloid leukemia. Previous case reports associated it with acute colitis. This is another report that demonstrates a link between dasatinib and chronic colitis akin to inflammatory bowel disease, in patients undergoing therapy with dasatinib for a prolonged time.\",\"PeriodicalId\":90205,\"journal\":{\"name\":\"Journal of cancer research & therapy\",\"volume\":\"21 1\",\"pages\":\"32-33\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-06-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of cancer research & therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14312/2052-4994.2017-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer research & therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14312/2052-4994.2017-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

达沙替尼是慢性髓性白血病患者的关键治疗选择。以前的病例报告将其与急性结肠炎联系起来。这是另一份报告，表明在长期接受达沙替尼治疗的患者中，达沙替尼与慢性结肠炎(类似炎症性肠病)之间存在联系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Colitis and chronic bleeding in patients treated with dasatinib

Dasatinib is a key therapeutic option in patients with chronic myeloid leukemia. Previous case reports associated it with acute colitis. This is another report that demonstrates a link between dasatinib and chronic colitis akin to inflammatory bowel disease, in patients undergoing therapy with dasatinib for a prolonged time.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of cancer research & therapy

自引率

0.00%

发文量